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ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV) is one of
the most economically important pathogens affecting many swine-producing re-
gions. Current vaccination strategies and antiviral drugs provide only limited protec-
tion. PRRSV infection can cleave mitochondrial antiviral signaling protein (MAVS) and
inhibit the induction of type I interferon. The antiviral effector molecules that are in-
volved in host protective responses to PRRSV infection are not fully understood.
Here, by using transcriptome sequencing, we found that a zinc ﬁnger antiviral pro-
tein, ZAP, is upregulated in MAVS-transfected Marc-145 cells and that ZAP sup-
presses PRRSV infection at the early stage of replication. We also found that the viral
protein Nsp9, an RNA-dependent RNA polymerase (RdRp), interacts with ZAP. The in-
teracting locations were mapped to the zinc ﬁnger domain of ZAP and N-terminal
amino acids 150 to 160 of Nsp9. These ﬁndings suggest that ZAP is an effective an-
tiviral factor for suppressing PRRSV infection, and they shed light on virus-host inter-
action.
IMPORTANCE PRRSV continues to adversely impact the global swine industry. It is
important to understand the various antiviral factors against PRRSV infection. Here, a
zinc ﬁnger protein, termed ZAP, was screened from MAVS-induced antiviral genes by
transcriptome sequencing, and it was found to remarkably suppress PRRSV replica-
tion and interact with PRRSV Nsp9. The zinc ﬁnger domain of ZAP and amino acids
150 to 160 of Nsp9 are responsible for the interaction. These ﬁndings expand the
antiviral spectrum of ZAP and provide a better understanding of ZAP antiviral mech-
anisms, as well as virus-host interactions.
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Porcine reproductive and respiratory syndrome (PRRS) is a viral disease characterizedby reproductive failure in sows and respiratory diseases in all pigs (1, 2). The
etiological agent of PRRS is porcine reproductive and respiratory syndrome virus
(PRRSV). It is a positive-sense single-stranded RNA virus belonging to the family
Arteriviridae (3), with a genome approximately 15 kb in length and carrying 10 open
reading frames (ORFs). ORF1a and ORF1b encode two long nonstructural polyproteins,
pp1a and pp1ab (4). pp1a is processed into Nsp1, Nsp1, Nsp2 to Nsp6, Nsp7,
Nsp7, and Nsp8. While proteolytic cleavage of pp1ab produces Nsp9 to Nsp12, which
are involved in viral transcription and replication. ORF2a, ORF2b, and ORF3 to ORF7
encode the structural proteins: glycoprotein GP2a, GP3, GP4, GP5, envelope (E), matrix
(M), and nucleocapsid (N) (5).
PRRS has caused signiﬁcant economic losses in the swine industry worldwide, and
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it is the most economically signiﬁcant porcine disease in China (6, 7). At present, there
are no adequate control strategies against it, due to antigenic and genomic diversity
among PRRSV isolates, the persistence of the virus in infected herds, and immunolog-
ical inhibition (8, 9). PRRSV has evolved a number of mechanisms to evade the host
immune response (2, 10) including inducing interleukin 10 and secretory CD83 to
suppress host immune responses (11–13) and inhibiting the induction of type I
interferon (IFN) (14–17). However, some host factors have been identiﬁed as having
antiviral functions against PRRSV, including myxovirus resistance 2 (MX2), viperin,
interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), and cholesterol
25-hydroxylase (CH25H) (18–22).
The innate immune response is the ﬁrst line of host defense against viral infections,
it is triggered by pattern recognition receptors, including Toll-like receptors, retinoic
acid induced gene I (RIG-I)-like receptors and so on (23, 24). In RIG-I-like receptor
pathways, RIG-I-like RNA helicases bind to viral RNA and activate the mitochondrial
antiviral-signaling protein (MAVS), which advances the signaling cascade by activating
the cytosolic kinases IB kinase (IKK) and TBK1, which in turn stimulate the transcription
factors NF-B and interferon regulatory factor 3 (IRF3), respectively. NF-B and IRF3
function cooperatively to induce type I IFN and other antiviral molecules (25–28).
Interferon binds to their receptors, activating the JAK-STAT signaling pathway, and
induces the expression of hundreds of interferon-stimulated genes (ISGs) (29). These
ISGs can target almost any step of the viral life cycle, but the complete molecular
mechanisms used by these ISGs in response to different pathogens are not fully
understood.
Here, in order to study the immune response of the host and enrich the data library
of antiviral factors against PRRSV, we activated the immune response of Marc-145 cells
by overexpressing MAVS and found that PRRSV replication was inhibited. Transcrip-
tome analysis of the MAVS-transfected cells showed that antiviral immune responses
were signiﬁcantly upregulated and induced the production of type I interferon and
numerous antiviral factors. Among the many other antiviral factors upregulated was a
CCCH-type zinc ﬁnger antiviral protein (ZAP). We cloned the ZAP gene for further study
and found that it inhibited the replication of PRRSV in Marc-145 cells, and this inhibition
was quickly started during the early stage of PRRSV replication. We found that PRRSV
Nsp9, an RNA-dependent RNA polymerase (RdRp), directly interacts with ZAP, and we
have demonstrated that ZAP plays an important role in the antiviral response of
Marc-145 cells, and when activated, can inhibit PRRSV replication.
RESULTS
MAVS mediates a powerful anti-PRRSV process in Marc-145 cells. MAVS is a
critical adaptor molecule for retinoic acid induced gene I (RIG-I) and melanoma
differentiation-associated gene 5 (MDA5) signal transduction (28). To explore the
interaction between PRRSV and the host, we examined (i) how PRRSV infection affects
the expression of endogenous MAVS in Marc-145 cells and (ii) how overexpression of
MAVS affects PRRSV infection. We found that PRRSV infection resulted in reduced
amounts of endogenous MAVS in a dose-dependent manner (Fig. 1A), and overexpres-
sion of MAVS inhibited PRRSV replication, even when challenge was at the highest
multiplicity of infection (MOI) (Fig. 1B). Overexpression of MAVS also signiﬁcantly
activated the promoter of IRF3 and NF-B (Fig. 1C). These results indicate that MAVS is
involved in the interaction between PRRSV and the host immune response and that
MAVS mediates a powerful anti-PRRSV process.
mRNA-seq of MAVS-transfected Marc-145 cells. To investigate host factors that
may inhibit PRRSV replication, transcriptome sequencing (mRNA-seq) of MAVS-
transfected Marc-145 cells was performed at 24, 36, and 48 h posttransfection (hpt). The
Venn diagram in Fig. 2A illustrates the number of differentially expression genes at each
time point. The top 50 upregulated genes and the top 20 downregulated genes were
selected for cluster analysis (Fig. 2B). In order to obtain an overall corroboration of the
mRNA-seq results, 6 upregulated and 3 downregulated genes were selected for quan-
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titative real-time reverse transcription-PCR (qRT-PCR). These results showed that the
altered expression of these 9 genes identiﬁed by mRNA-seq was consistent with the
results of qRT-PCR (Fig. 2C). The biological processes of MAVS-upregulated genes were
mainly viral defense responses, type I interferon-mediated signaling, and negative
regulation of viral genome replication (Fig. 2D). The genes associated with antiviral
responses are listed in Fig. 2E. The results demonstrate that MAVS actives the host
immune response, including induction of numerous antiviral factors.
Effects of the candidate novel antiviral factors on PRRSV replication. Seven
MAVS-induced antiviral genes (encoding IFI6, APOBEC3H [A3H], PLSCR1, TRIM22,
ZC3HAV1 [ZAP], DTX3L, and MX2) were selected for further investigation into their
effects on PRRSV replication (Fig. 3A). Western blotting results revealed that ZAP
and MX2 signiﬁcantly suppress PRRSV replication, whereas A3H, TRIM22, PLSCR1, and
DTX3L do not (Fig. 3B). The cell viability assay demonstrated that the growth and
viability of all transfected cell populations were comparable (Fig. 3C). The effect of
ZAP-L (the long isoform of ZAP) on PRRSV replication was also examined. The results
showed that the inhibitory effect of ZAP-L is similar to that of ZAP (Fig. 3D).
Overexpression of ZAP inhibits PRRSV replication. To further investigate the
effect of ZAP on PRRSV replication, Marc-145 cells were transfected with pHA-ZAP
and/or pHA-EV for 24 h and then infected with PRRSV at an MOI of 0.1. Western blotting
and qRT-PCR results showed that overexpression of ZAP results in a marked decrease
in N protein and PRRSV ORF7 mRNA expression in a ZAP dose-dependent manner (Fig.
4A and B). Progeny virus production in these supernatants was signiﬁcantly decreased
in a ZAP dose-dependent manner, as determined by the 50% tissue culture infective
dose (TCID50) (Fig. 4C). Indirect immunoﬂuorescence assay (IFA) results showed that the
amount of PRRSV detectable in cells, as determined by N-protein ﬂuorescence, was
FIG 1 Interaction of MAVS and PRRSV in vitro. (A) Expression of endogenous MAVS in PRRSV-infected Marc-145
cells. Marc-145 cells were cultured in 6-well plates, challenged with PRRSV at an MOI of 0.01, 0.1, or 1 for 30 h, and
then harvested for Western blotting. (B) Effect of MAVS on PRRSV replication. Marc-145 cells were seeded into
24-well plates and transfected with the MAVS-expressing plasmid or empty vector (EV). At 24 h posttransfection,
the cells were challenged with PRRSV at an MOI of 0.1, incubated for 30 h, and then assayed by Western blotting.
(C) Luciferase activity assay was performed on Marc-145 cells cotransfected with IRF3 or NF-B luciferase reporter
plasmids and MAVS-expressing plasmid or empty vector (EV). Fold induction was measured relative to empty
vector. **, P  0.01.
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FIG 2 Transcriptome sequencing of MAVS-transfected Marc-145 cells. Marc-145 cells were transfected with the MAVS plasmid or empty vector
(EV). Total RNA extraction was performed at 24, 36, and 48 hpt, followed by transcriptome sequencing. (A) Venn diagrams of the number of genes
upregulated and downregulated (2-fold change) by MAVS. (B) Differentially expressed genes selected for cluster analysis, included the 50 most
upregulated genes and the 20 most downregulated genes. Red indicates increased gene expression levels, and blue indicates decreased levels
(Continued on next page)
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reduced in a ZAP dose-dependent manner (Fig. 4D). In addition, overexpressing ZAP
signiﬁcantly inhibited the replication of each of the subtype strains of PRRSV which
include the classical strain S1, the highly pathogenic strain BB0907, the NADC30-like
strain FJ1402, and the new subgenotype strain GD1404 (Fig. 4E). These results show
that ZAP inhibits PRRSV replication in a ZAP dose-dependent and PRRSV strain-
independent manner.
Knockdown of ZAP enhances PRRSV replication. Marc-145 cells were transfected
with small interfering RNA (siRNA) targeting ZAP or NC siRNA for 24 h and then
challenged with PRRSV at an MOI of 0.1. At 30 h postinfection (hpi), cells were collected
to determine ZAP mRNA and protein levels by qRT-PCR and Western blotting and to
FIG 2 Legend (Continued)
(compared with normal samples). (C) Validation of mRNA-seq data by qRT-PCR analyses. The IFN-, MX2, viperin, PLSCR1, ZAP, and XAF1 genes
were upregulated, and the CLDN2, KRT19, and ANGPT1 genes were downregulated (compared with normal controls). (D) Gene ontology (GO)
network analysis of pathways signiﬁcantly upregulated by MAVS. (E) List of the upregulated genes associated with the PRRSV antiviral response.
FIG 3 Effect of the candidate novel antiviral factors on PRRSV replication. (A) List of candidate genes for screening
of novel anti-PRRSV factors. (B) Western blot of transfected Marc-145 cells challenged with PRRSV for 30 h. (C) Cell
viability assay on cells overexpressing the candidate antiviral genes. (D) Western blot of ZAP-L (long isoform of
ZAP)- and ZAP-transfected Marc-145 cells challenged with PRRSV for 30 h. The data presented are means  SD
from three independent experiments.
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determine PRRSV replication. The results showed that the transcription level and
protein expression of endogenous ZAP were signiﬁcantly reduced by transfection of
siZAP-2 and siZAP-3, while siZAP-1 had no effect on ZAP expression (Fig. 5A and B).
Knockdown of ZAP signiﬁcantly enhanced the replication of PRRSV in Marc-145 cells
(Fig. 5B and C). Furthermore, the restriction of PRRSV replication by ZAP was restored
by overexpressing ZAP in the knockdown cells (Fig. 5D). These results indicate that ZAP
is part of the host defense mechanism against PRRSV infection.
ZAP suppresses PRRSV replication at the early stage of replication. To identify
which step of the PRRSV life cycle was restricted by ZAP, viral binding and entry were
explored. Two cultures each of ZAP- or empty vector (EV)-transfected Marc-145 cells
were incubated with PRRSV at an MOI of 0.1 at 4°C for 1 h. One group of cells in each
culture were washed with phosphate-buffered saline (PBS), and bound virus was
measured by quantitating viral mRNA by qRT-PCR. The second group of cultures was
shifted to 37°C for 2 h, cells were then washed to remove all unincorporated virus, and
the intracellular viral RNA was quantiﬁed using qRT-PCR (Fig. 6A). The results showed
that there was no signiﬁcant difference in the amount of PRRSV bound or internalized
between ZAP- and EV-transfected cells (Fig. 6B). These data demonstrate that overex-
pressing ZAP does not block the process of viral binding or entry.
Kinetic studies were performed to investigate the antiviral action of ZAP on PRRSV
replication. The PRRSV transcriptional levels in ZAP-transfected cells were quantiﬁed by
FIG 4 Overexpression of ZAP inhibits PRRSV replication. (A) Western blot of pHA-ZAP- and/or empty vector (EV)-
transfected Marc-145 cells challenged with PRRSV for 30 h. The expression of viral N protein and ZAP protein in cell lysates
was determined with anti-N and anti-HA antibodies. (B) Viral RNA was assessed using qRT-PCR. (C) Virus yields in the
supernatants were assayed and are presented as TCID50 per milliliter. (D) PRRSV in the cells was detected by IFA. (E)
Western blot of intracellular PRRSV N protein from transfected Marc-145 cells challenged with either the classical strain S1,
the highly pathogenic strain BB0907, the NADC30-like strain FJ1402, or the new subgenotype GD1404. Each sample was
run in triplicate. *, P  0.05; **, P 0.01.
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qRT-PCR at various time points postinfection, and viral N-protein expression was
detected by Western blotting. The results showed there were no signiﬁcant differences
in transcriptional levels at 2 hpi, again demonstrating that overexpressing ZAP does not
affect the entry of PRRSV into the cells. However, the amount of viral RNA was
signiﬁcantly reduced in ZAP-overexpressing cells from 4 hpi to the end of the assay
period at 36 hpi (Fig. 6C). Similarly, Western blotting results showed that the expression
of PRRSV N protein was signiﬁcantly suppressed by ZAP (Fig. 6D). Taken together, these
results indicate that ZAP initiates the suppression of PRRSV replication at the early stage
of PRRSV replication.
Screening PRRSV proteins for interaction with ZAP. 293T cells were cotrans-
fected with plasmids expressing hemagglutinin (HA)-tagged ZAP and Flag-tagged
PRRSV proteins. Coimmunoprecipitation (co-IP) assays were performed with anti-HA
polyclonal antibody (PAb) and anti-Flag monoclonal antibody (MAb) at 48 h posttrans-
fection. The immunoprecipitation results demonstrate that HA-ZAP interacts with
Flag-Nsp9 but not with the other viral proteins. (Fig. 7A). To preclude nonspeciﬁc
interaction mediated by RNA, the cell lysates were treated with RNase A prior to co-IP.
The results conﬁrmed that the interaction of ZAP and Nsp9 was RNA independent (Fig.
7B). Furthermore, confocal microscopy illustrated the colocalization of ZAP and Nsp9 in
the cytoplasm of HA-ZAP- and Flag-Nsp9-cotransfected cells (Fig. 7C). Taken together,
those data demonstrate that ZAP interacts with the Nsp9 of PRRSV.
The zinc ﬁnger domain of ZAP mediates the antiviral response and interaction
with Nsp9. ZAP has a zinc ﬁnger domain at its N terminus and a WWE domain at its C
FIG 5 Knockdown of ZAP enhances PRRSV replication. (A) Quantiﬁcation by qRT-PCR of the ZAP gene in siZAP-1-, siZAP-2-,
siZAP-3-, or siNC-transfected Marc-145 cells. (B) Western blot of PRRSV-N and endogenous ZAP in transfected Marc-145
cells challenged with PRRSV for 30 h. A control group of ZAP expression and virus replication with just transfection reagent
was included (no-treat). (C) Viral titers in these supernatants, presented as TCID50. (D) The ZAP plasmid was transfected into
the cells with knockdown of the ZAP gene with siZAP-2. A no-siRNA (no-treat) group was used as control of virus
replication. The cells were infected with PRRSV at an MOI of 0.1. After incubation for 30 h, the viral titers in these
supernatants were assayed and are presented as TCID50. Data are expressed as the means  SD from three independent
experiments. ns, not signiﬁcant; *, P 0.05; **, P 0.01.
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terminus, whereas the ZAP long isoform (ZAP-L) also contains a poly(ADP-ribose)
polymerase (PARP) domain at its C terminus (30) (Fig. 8A). To map the functional
domain of ZAP required for inhibiting PRRSV replication, we constructed several
HA-tagged truncations of ZAP. Marc-145 cells were transfected with these plasmids for
24 h and then challenged with PRRSV at an MOI of 0.1. After incubation for 30 h, the
cells and supernatants were harvested for Western blotting and virus titration. The
results showed that ZAP-N (the zinc ﬁnger domain of ZAP) exhibited inhibition of
PRRSV replication similar to that of ZAP and ZAP-L. However, the WWE domain or the
PARP domain had no effect on PRRSV replication (Fig. 8B and C), suggesting that the
zinc ﬁnger domain of ZAP is necessary and sufﬁcient for ZAP antiviral activity. Further-
more, co-IP assay results showed that Nsp9 interacts with ZAP-N as well as with ZAP
and ZAP-L but not with the WWE or PARP domain (Fig. 8D). Collectively, these results
suggested that the zinc ﬁnger domain of ZAP is crucial for its antiviral activity and its
interaction with Nsp9.
The region from aa 150 to 160 of Nsp9 is required for the interaction with ZAP.
To investigate the region of Nsp9 required for binding to ZAP, the spatial structures of
Nsp9 of PRRSV were predicted using I-TASSER (https://zhanglab.ccmb.med.umich.edu/
I-TASSER/). The predicted structure possesses an independent domain at the N termi-
nus (amino acids [aa] 1 to 177) and a compact structure at the C terminus (aa 449 to
643) (Fig. 9A). Based on these structures, ﬁve Flag-tagged truncated mutants of
Nsp9-expressing plasmids were constructed, including aa 1 to 177, 178 to 449, 450 to
643, 1 to 449, and 178 to 643 (Fig. 9B). 293T cells were cotransfected with the
Flag-tagged Nsp9 or its truncations and HA-tagged ZAP and incubated for 48 h. The
co-IP results showed that the Nsp9 aa 1 to 177, Nsp9 aa 1 to 449, and the full-length
Nsp9 could interact with ZAP. In contrast, ZAP had no interaction with other truncations
(Fig. 9C), indicating that the region of aa 1 to 177 of Nsp9 is responsible for the
interaction with ZAP.
FIG 6 Effects of ZAP on the PRRSV life cycle. (A) Overview of the experimental design to examine virus binding and entry. (B) qRT-PCR
results for viral RNA (0 and 2 hpi) in pHA-ZAP- or empty vector-transfected Marc-145 cells challenged with PRRSV. (C) qRT-PCR results for
viral RNA (2 to 36 hpi) in pHA-ZAP- or empty vector-transfected Marc-145 cells. (D) Western blot of PRRSV-N protein in the lysates of these
cells. Data are expressed as the means  SD from three independent experiments. ns, not signiﬁcant; *, P 0.05; **, P 0.01.
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To further narrow down the Nsp9-ZAP-interacting region of Nsp9, further trunca-
tions were made only within the region from aa 1 to 177 of Nsp9: aa 60 to 643, 119 to
643, 150 to 643, 160 to 643, and 170 to 643 (Fig. 9D). Similarly, a co-IP assay was
performed to determine the interacting region. As shown in Fig. 9E, the regions from
aa 60 to 643, 119 to 643, and 150 to 643 and the full-length Nsp9 coimmunoprecipi-
tated with ZAP, whereas the regions from aa 160 to 643 and aa 170 to 643 did not.
These results suggest that the critical region of Nsp9 for interaction with ZAP is in the
region of amino acids 150 to 160.
DISCUSSION
PRRSV is one of the most important economically damaging pathogens in the swine
industry globally. The interaction of PRRSV and the host immune response is compli-
cated and not fully understood. In this study, we screened several candidate antiviral
factors in MAVS-mediated antiviral immune pathways by transcriptome sequencing.
We found that ZAP effectively inhibits the replication of PRRSV in Marc-145 cells and
FIG 7 ZAP interacts with the Nsp9 of PRRSV. (A) Western blot of Flag-tagged PRRSV proteins and HA-tagged ZAP from whole-cell lysates (WCL) of
cotransfected 293T cells and of the proteins immunoprecipitated with rabbit anti-HA. (B) Western blot showing that the ZAP-Nsp9 interaction is independent
of RNA. pFlag-Nsp9- and pHA-ZAP-cotransfected cell lysates were collected and treated with RNase A, and then co-IP was performed using mouse anti-Flag.
(C) Colocalization of ZAP and Nsp9. Cotransfected 293T cells were stained for Flag-Nsp9 (green) and HA-ZAP (red), with nuclei stained with the DNA-binding
dye DAPI (blue). Experiments were performed in triplicate.
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that ZAP interacts with the viral RNA-dependent RNA polymerase (RdRp) Nsp9. This
suggests that ZAP may play a critical role in the innate immune response to suppress
PRRSV infection.
ZAP, also known as ZC3HAV1, is a CCCH-type zinc ﬁnger antiviral protein. ZAP can
inhibit the replication of Moloney murine leukemia virus, Sindbis virus, Ross River virus,
Ebola virus, Marburg virus, and hepatitis B virus (31–34). ZAP can directly bind viral
mRNA and prevent the accumulation of viral RNA in the cytoplasm, and it can also
recruit the RNA exosome to degrade target viral RNA (35–37). In addition, ZAP inhibits
human immunodeﬁciency virus (HIV) infection by selectively targeting multiply spliced
viral RNA for degradation (38). These ﬁndings suggest that ZAP is a trans-acting factor
that modulates mRNA stability. In this study, our results showed that overexpressing
ZAP does not block the process of viral binding or entry but that ZAP initiates the
suppression of PRRSV replication at the early stage of PRRSV replication. At the early
FIG 8 The zinc ﬁnger domain of ZAP mediates the antiviral response and the interaction with Nsp9. (A) Schematic of ZAP domains.
The truncations of ZAP were constructed according to the schematic. (B and C) The zinc ﬁnger domain of ZAP is necessary and
sufﬁcient for ZAP antiviral activity. Transfected Marc-145 cells were challenged with PRRSV, and then the cells and supernatant were
harvested for Western blotting (B) and virus titration (C). (D) Western blot of co-IP from HA-tagged ZAP truncation- and Flag-tagged
Nsp9-cotransfected 293T cells. Experiments were performed three times. Data are expressed as the means  SD. ns, not signiﬁcant;
**, P 0.01.
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FIG 9 The region from aa 150 to 160 of Nsp9 interacts with ZAP. (A) Predicted three-dimensional structure of Nsp9
of PRRSV strain BB0907, presented in surface (left) and cartoon (right) formats. (B) Schematic of the Nsp9
truncations used for co-IP. (C) Western blot of co-IP from HA-tagged ZAP- and Flag-tagged Nsp9 truncation-
cotransfected 293T cells. (D) Schematic of the truncations made in Nsp9 amino acids 1 to 177. (E) Western blot of
co-IP from HA-tagged ZAP- and Flag-tagged Nsp9 truncation (aa 1 to 177)-cotransfected 293T cells. WT, wild type.
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stage, when PRRSV replication is still in a single cycle, ZAP may interrupt viral RNA
synthesis, and then ZAP may also target the viral RNA for degradation. We also note an
approximately 2-fold difference in RNA replication in the presence of ZAP through
about 18 hpi, which then suddenly increased to over a log by 36 hpi (Fig. 6). The
increased difference in RNA at later times might be due to defects during the ﬁrst round
of replication that were independent of RNA production. ZAP preferentially targets CG
dinucleotides for binding and recognition in HIV (39). We analyzed the amount of CG
dinucleotides of the PRRSV BB0907 genome in a previous study (40). The CG content
is 52.13%, and the relative abundance of CG dinucleotides is 1.42, which is a high
relative abundance compared with a random association of mononucleotides (41).
Whether ZAP inhibits PRRSV replication by binding and degrading viral RNA requires
further investigation.
PRRSV has various Nsps in replicases ORF1a and ORF1b that participate in PRRSV
RNA synthesis, in particular the viral Nsp9 and RNA helicase Nsp10 (4, 36). To investigate
whether ZAP interrupts PRRSV RNA synthesis by interacting with PRRSV functional
proteins, all of the viral structural and nonstructural protein genes except those for
Nsp2, GP2, and GP4 were subjected to co-IP assay. The results showed that only the
viral RNA polymerase Nsp9 interacts with ZAP. PRRSV Nsp9 contains a putative RNA-
dependent RNA polymerase (RdRp) domain at the C terminus, and the N terminus of
Nsp9 has a newly identiﬁed nidovirus RdRp-associated nucleotidyltransferase (NiRAN)
domain (4, 42). PRRSV Nsp9 is considered to be a core component of the viral
replication and transcription complex (RTC) (43). PRRSV Nsp9 not only possesses RNA
polymerase activity but also interacts with the N protein of PRRSV to regulate viral RNA
synthesis (44). Moreover, it has been reported that Nsp9 interacts with other cellular
proteins, including annexin A2, retinoblastoma protein, and DEAD box RNA helicase 5;
these interactions beneﬁt the replication of PRRSV (45–47). In this study, our results
showed that ZAP interacts with Nsp9 and suppresses the replication of PRRSV. The
regions of Nsp9 critical to the interaction with ZAP are located between amino acid
residues 150 and 160, which belong to the NiRAN domain. Recent research has
indicated that NiRAN is essential for replication of nidoviruses, including PRRSV. Po-
tential functions supported by NiRAN may include nucleic acid ligation, mRNA capping,
and protein-primed RNA synthesis (42). We speculate that the interaction between ZAP
and the RNA polymerase Nsp9 interferes with the functions of NiRAN and impedes the
synthesis of the PRRSV genome, thereby suppressing PRRSV replication. Of course, this
speculation remains to be veriﬁed in future studies.
ZAP contains four CCCH-type zinc ﬁnger motifs at its N terminus, and ZAP binds
directly to speciﬁc viral RNA sequences through these zinc ﬁnger motifs (35, 37). In this
study, the zinc ﬁnger domain is also proved to be responsible for the interaction with
PRRSV Nsp9. And the zinc ﬁnger domain was found to be necessary and sufﬁcient for
ZAP to restrict PRRSV replication. These results establish that the zinc ﬁnger motifs play
an important role in the antiviral activity of ZAP.
In addition to acting as a cellular restriction factor against virus infection, ZAP is also
a potent stimulator of signaling mediated by RIG-I during antiviral responses (48, 49).
RIG-I is an important cytosolic pattern recognition receptor (PRR) that triggers innate
immune defenses against a variety of RNA viruses (25). Here, we found that ZAP
reduced the PRRSV replication at the early stage of infection. We speculate that the
synthesis of the PRRSV genome was impeded by the interaction of ZAP with the viral
RNA-dependent RNA polymerase (RdRp) Nsp9. Whether ZAP inhibits PRRSV replication
by boosting the early antiviral response mediated by RIG-I or by interacting with other
host cofactors requires further investigation.
In summary, we found that ZAP is an efﬁcient cell-intrinsic antiviral factor against
PRRSV replication due to its interaction with viral Nsp9. The critical regions of interac-
tion between ZAP and Nsp9 were mapped to the zinc ﬁnger domain of ZAP and amino
acid residues 150 to 160 of Nsp9. These ﬁndings should be helpful in understanding the
host antiviral response to PRRSV infection.
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MATERIALS AND METHODS
Cells and viruses. PRRSV-permissive Marc-145 (monkey kidney) cells and human embryonic kidney
(HEK293T) cells were cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Invitrogen) containing
10% fetal bovine serum (Gibco) at 37°C in a humidiﬁed atmosphere containing 5% CO2. The highly
virulent PRRSV strain BB0907 (GenBank accession no. HQ315835.1) was used for all experiments and is
the strain represented by “PRRSV” in this article unless otherwise speciﬁed. The classical PRRSV strain S1,
the PRRSV NADC30-like strain FJ1402 (GenBank accession no. KX169191.1), and a new subgenotype
PRRSV strain, GD1404 (GenBank accession no. MF124329.1), were isolated and stored in our laboratory.
mRNA-seq. Marc-145 cells were transfected with MAVS plasmid or empty vector. After being
incubated for 24, 36, and 48 h, total RNA was extracted from the transfected cells using TRIzol. An
amount of 2 g of total RNA was treated twice by using a poly(A) mRNA magnetic isolation module
(NEB). After selection, the mRNA was fragmented, and sequencing libraries were prepared using a Kapa
Stranded RNA-Seq Library Prep kit (Illumina). Gene expression data were obtained by sequencing using
an Illumina HiSeq 4000 instrument. The differentially expressed genes were considered to be signiﬁcant
at a Q value of 0.005 and absolute fold change of 2. Genes with signiﬁcant similarities to the
transcripts were selected for gene ontology (GO) analysis, based on the DAVID database (50).
Construction of plasmids and transfection of cells. Seven ISGs, i.e., those for IFI6, APOBEC3H (A3H),
PLSCR1, TRIM22, ZC3HAV1 (ZAP), MX2, and DTX3L, were selected from the MAVS-mediated antiviral
related pathways and PCR ampliﬁed for plasmid construction. The amplicons was cloned into pCAGGS
vectors (Addgene) containing a C-terminal HA tag and sequenced. Genes of PRRSV structural and
nonstructural proteins were cloned into the pCI-neo vector (Promega) containing an N-terminal Flag tag.
Truncations of pHA-ZAP and pFlag-Nsp9 were subcloned from the pCA-ZAP and pCI-Nsp9 plasmids,
respectively. The ampliﬁcation primers used are listed in Table 1. Marc-145 and 293T cells were
transfected with plasmids using Lipofectamine 3000 according to the manufacturer’s instructions.
Luciferase reporter assay. Marc-145 cells cultured in 24-well plates were cotransfected with 500 ng
of MAVS expressing plasmid or empty vector, 400 ng of IRF3 or NF-B luciferase reporter plasmid, and
100 ng of Renilla luciferase construct (pRL-TK), which served as an internal control. At 24 h posttrans-
fection (hpt), the cells were harvested and the luciferase activity was measured with a dual-luciferase
reporter assay system (Promega). Relative luciferase activity was normalized to that of a control. All assays
were performed in triplicate.
Virus challenge and titration. To detect the effects of screened ISGs on the replication of PRRSV,
Marc-145 cells were transfected with plasmids containing an HA-tagged ISG or empty vector (EV). At 24 h
posttransfection, cells were challenged with PRRSV at an MOI of 0.1 (0.7 TCID50/cell is deﬁned as an MOI
of 1) for 30 h. To detect the effects of knockdown of ZAP on PRRSV replication, Marc-145 cells were
transfected with the indicated siRNA. At 24 h posttransfection, cells were challenged with PRRSV at an
MOI of 0.1 and incubated for 30 h. Virus progeny production in the supernatants was determined by
TCID50. Brieﬂy, Marc-145 cells were seeded into 96-well plates at 24 h before virus titration. Virus
supernatants were prepared by 10-fold serial dilution, and 100-l volumes of the dilutions were added
per well in replicates of eight. At 5 days postinfection, the TCID50 was calculated using the Reed-Muench
method.
TABLE 1 Primers used in this study
Primer Sequence (5= ¡ 3=) Usage
HA-ZAP-F CCGGAATTCGCCACCATGGCGGACCCGGAGGTGTG Ampliﬁcation of ZAP and ZAP-L
HA-ZAP-R CGGGGTACCTCAAGCGTAATCTGGAACATCGTATGGGTACTCTGGCCCTCTCTTCATC Ampliﬁcation of ZAP and ZAP-M
HA-ZAP-L-R CGGGGTACCTCAAGCGTAATCTGGAACATCGTATGGGTAACTAATCACGCAGGCTTTG Ampliﬁcation of ZAP-L and ZAP-C
HA-ZAP-N-R CGGGGTACCTCACTTATCGTCGTCATCCTTGTAATCGTTTCTACGATGTGAAGA Ampliﬁcation of ZAP-N
HA-ZAP-M-F CCGGAATTCGCCACCATGGCGTATAGGGCTAGA Ampliﬁcation of ZAP-M
HA-ZAP-C-F CCGGAATTCGCCACCATGCGTCAGCCAGCACAGACCTCG Ampliﬁcation of ZAP-C
Flag-Nsp9-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGTTTAAACTGCTAGCCG Ampliﬁcation of Nsp9 and 1–177/449
Flag-Nsp9-R CCGCTCGAGTCACTCATGATTGGACCTG Ampliﬁcation of Nsp9 and 60/119/
150/160/170–643
Flag-Nsp9 177-R CCGCTCGAGTCAGCTTCCAGTGTCACTG Ampliﬁcation of Nsp9 1–177
Flag-Nsp9 449-R CCGCTCGAGTCAGCCGCCTCTCTTAGTCAC Ampliﬁcation of Nsp9 1–449
Flag-Nsp9 178-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGCCGGTGCATGCAGCTG Ampliﬁcation of Nsp9 178–449/643
Flag-Nsp9 450-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGCTTTCGTCTGGCGACCCG Ampliﬁcation of Nsp9 450–643
Flag-Nsp9 60-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGGTTGCCCGACCGGTTGA Ampliﬁcation of Nsp9 60–643
Flag-Nsp9 119-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGGTTGCACTCAGTGCGCA Ampliﬁcation of Nsp9 119–643
Flag-Nsp9 150-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGGGCAACCCTGAGCGGGT Ampliﬁcation of Nsp9 150–643
Flag-Nsp9 160-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGCAGAATACAAGGTTTG Ampliﬁcation of Nsp9 160–643
Flag-Nsp9 170-F CGGGGTACCGCCACCATGGATTACAAGGATGACGACGATAAGAAAACCCCCAGTGACAC Ampliﬁcation of Nsp9 170–643
Q-PRRSV-N-F AAACCAGTCCAGAGGCAAGG qRT-PCR for detection of PRRSV
Q-PRRSV-N-R TCAGTCGCAAGAGGGAAATG
Q-ZAP-F CCACATCTTCTAGGGTGGATGA qRT-PCR for detection of ZAP
Q-ZAP-R CGTCCAGGTTTCACCAATAAACA
Q-GAPDH-F GAAGGTGAAGGTCGGAGTC qRT-PCR for detection of GAPDHa
Q-GAPDH-R GAAGATGGTGATGGGATTTC
aGAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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Cell viability assay. A cell viability assay was performed using the Cell Counting Kit-8 (CCK-8)
(Beyotime) according to the manufacturer’s instructions. Results were expressed relative to those for
control cells, deﬁned as 100% viability.
siRNA knockdown. All siRNAs (Invitrogen) were transfected with Lipofectamine 3000 according to
the manufacturer’s instructions. Marc-145 cells were plated into 24-well plates, and when 60% conﬂuent,
cells were transfected with 50 pmol of siRNA. To determine the efﬁciency of the knockdown, total RNA
was extracted from the cells at 24 h posttransfection, and endogenous ZAP mRNA was quantiﬁed by
qRT-PCR. In parallel, cells were lysed, and proteins were separated by SDS-PAGE, transferred to nitro-
cellulose, and probed with polyclonal anti-ZAP antibodies (1:2,000) (Proteintech). The siRNA sequences
are as follows: siZAP-1, 5=-CUU CUA CCA GAU CCU UAA ATT-3=; siZAP-2, 5=-GAA AUG AGU UGU GAU UUC
ATT-3=; siZAP-3, 5=-GAU UCU UUA UCU GAU GUC ATT-3=. The nontargeting control siRNA (siNC) sequence
is 5=-UUC UCC GAA CGU GUC ACG UTT-3=.
Virus binding and entry assays. Marc-145 cells cultured in 24-well plates were transfected with
either pHA-ZAP or empty vector for 24 h. For the virus binding assay, Marc-145 cells were challenged
with PRRSV at an MOI of 0.1 at 4°C for 1 h to allow virions to bind to, but not enter, cells. After washing
cells with cold phosphate-buffered saline (PBS), bound virions were measured by qRT-PCR. For the virus
entry assay, cells were incubated with PRRSV at 4°C for 1 h, washed with cold PBS, overlaid with warmed
DMEM, and incubated at 37°C for 2 h to allow virions to enter the cells (the time point at which the cells
were shifted to 37°C is set as 0 h). The cells were then washed with cold alkaline high-salt solution (1 M
NaCl and 50 mM sodium bicarbonate [pH 9.5]) for 3 min to remove cell-surface-associated viruses (51).
After being washed twice with cold PBS, the cells were trypsinized and collected for qRT-PCR assay. Virus
entry was quantiﬁed by qRT-PCR of intracellular PRRSV RNA.
Viral replication kinetics. Marc-145 cells cultured in 12-well plates were transfected with either
pHA-ZAP or empty vector for 24 h and then challenged with PRRSV at an MOI of 0.1. Cells were collected
at various time points over 36 h after infection and divided for RNA and protein extraction. PRRSV
replication kinetics were analyzed at the viral transcription level by qRT-PCR, and the viral protein level
was measured by Western blotting.
IFA. For indirect immunoﬂuorescence assay (IFA), Marc-145 cells (transfected or infected) plated in
24-well plates were washed three times with PBS, ﬁxed for 20 min with 4% paraformaldehyde, and then
permeabilized for 30 min with 0.1% Triton X-100. The ﬁxed cells were incubated with a monoclonal
antibody to PRRSV N protein (2H7, made in our laboratory) (1:100) for 2 h at 37°C. Following three washes
with PBS, the cells were incubated with Alexa Fluor 488-conjugated goat anti-mouse IgG (1:100)
(Beyotime) for 1 h at 37°C. After washing again with PBS, ﬂuorescence images were observed using
ﬂuorescence microscopy (Nikon).
qRT-PCR. For quantitative real-time RT-PCR (qRT-PCR), total RNAs were isolated from PRRSV-
infected cells using the Total RNA kit (Omega) and reverse transcribed into cDNA with HiScript QRT
SuperMix for qPCR (Vazyme) according to the manufacturer’s instructions. qRT-PCR primers are listed
in Table 1.
Co-IP and Western blotting. For the coimmunoprecipitation assay, 293T cells were cotransfected
with HA-tagged ZAP and Flag-tagged PRRSV genes or plasmids expressing Nsp9 truncations. At 48 h
posttransfection, cells were washed with cold PBS and lysed with cell lysis buffer for Western blotting and
IP (Beyotime). Cell lysates were centrifuged at 12,000 g for 10 min, supernatants were incubated with
mouse anti-Flag monoclonal antibody (1 g) (Abmart) or rabbit anti-HA polyclonal antibody (1 g)
(Proteintech) at 4°C for 8 h, and then 30 l of protein A/G-agarose (Beyotime) was added to each lysate
and incubation continued for 3 h at 4°C. The beads were collected by centrifugation at 2,500 g for 5
min and washed ﬁve times with cold PBS. The bound proteins were subjected to SDS-PAGE, transferred
to nitrocellulose, and probed with rabbit anti-FLAG PAb (1:5,000) or mouse anti-HA MAb (1:5,000)
(Proteintech).
For Western blotting, equal amounts of protein were subjected to SDS-PAGE and electrotransferred
to nitrocellulose membranes (Pall). Membranes were blocked in 5% nonfat milk for 2 h at room
temperature and then incubated with the indicated antibodies. Following three washes in PBS-Tween,
membranes were incubated with either horseradish peroxidase (HRP)-conjugated goat anti-rabbit or
goat anti-mouse antibody (1:1000) (Beyotime) for 1 h at room temperature. After washing, proteins were
detected using an ECL kit (Tanon).
Confocal microscopy. 293T cells were cotransfected with pHA-ZAP and pFlag-Nsp9 for 48 h.
Transfected cells were then ﬁxed and permeabilized with precooled isometric methyl alcohol and
acetone (1:1) for 10 min, blocked in 1% bovine serum albumin for 30 min, and then incubated with
mouse anti-Flag (1:1,000) or rabbit anti-HA (1:100) for 2 h at 37°C. After washing with PBS, the cells were
incubated with Alexa Fluor 488-conjugated goat anti-mouse IgG(HL) and Alexa Fluor 647-conjugated
goat anti-rabbit IgG(HL) (1:200) (Beyotime) for 1 h at 37°C. Cells were washed again with PBS and then
stained with 4’,6-diamidino-2-phenylindole (DAPI) for 10 min at room temperature. Cells were examined
using confocal microscopy (Nikon A1).
Statistical analysis. Statistical analysis was performed using GraphPad Prism5 software. Results were
expressed as the mean  standard deviation (SD). Differences between groups were examined for
statistical signiﬁcance using one-way or two-way analysis of variance (ANOVA). The asterisks in the
ﬁgures indicate signiﬁcant differences (*, P  0.05; **, P  0.01; ns, not signiﬁcant).
Data availability. All sequencing data ﬁles are available through the NCBI GEO repository as record
GSE111530.
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